Wroclaw

Poland

838 total trials 311 recruiting

Filter these 838 trials by phase, condition, sponsor and more.

Open in Search →

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening); … Ended recruitment

2024-519000-27-00 5 2025-07-17 Hypertension
A Study of Two Doses of Ritlecitinib in People 12 Years of Age and Older with Alopecia Areata Ended recruitment

2024-519370-40-00 5 2025-07-16 Alopecia areata
A Trial to Study the Safety and Efficacy of a New Drug Combination for Weight Loss While Maintaining Muscles Ended recruitment

2024-519561-22-00 4 2025-07-07 Obesity
A Phase 2b to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With ACPA-Positive Rheumatoid Arthritis Ended recruitment

2024-515973-82-00 4 2025-06-23 ACPA-Positive Rheumatoid Arthritis
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARIT … Ended recruitment

2024-515523-11-00 5 2025-06-09 Chronic Weight Management
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) A Study of Orforglipron (LY3502970) in Adolescent Partici … Ended recruitment

2024-514081-40-00 5 2025-06-06 Obesity, Overweight
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled … Ended recruitment

2024-516815-26-00 5 2025-05-30 Chronic rhinosinusitis with nasal polyps
A Phase 2 Open-Label Safety and Efficacy Study of PF-06835375 Ended recruitment

2023-509338-21-00 4 2025-05-28 Primary immune thrombocytopenia
Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakizumab in subjects with moderate to severe genital psoriasis. Ended recruitment

2024-515672-12-00 5 2025-05-27 Moderate to Severe Genital Psoriasis
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled … Ended recruitment

2024-516814-39-00 5 2025-05-20 Chronic rhinosinusitis with nasal polyps
A Randomized, Active-Controlled, Double-Blind, Phase 3 Study to Compare Efficacy and Safety of CT-P55 with Cosentyx in Patients with Moderat … Ended recruitment

2024-513348-27-00 5 2025-05-09 Plaque psoriasis
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Progressive Metastatic Castration- … Ended recruitment

2024-513968-25-00 5 2025-04-28 Metastatic castration-resistant prostate cancer (mCRPC)
AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTI … Ended recruitment

2023-505601-16-00 5 2025-04-22 Chronic Migraine
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended recruitment

2024-516609-22-00 5 2025-04-15 Primary Sjögren’s Disease
A research study comparing how well different doses of the medicine NNC0519-0130 can reduce kidney damage in people living with chronic kidn … Ended recruitment

2024-510846-15-00 4 2025-04-14 Chronic Kidney Disease, with or without Type 2 diabetes, Obesity
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-naïve Participants with Active Psoriatic Arthritis Ended recruitment

2023-509239-19-00 5 2025-04-03 Active Psoriatic Arthritis
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active … Ended recruitment

2024-516213-20-00 5 2025-03-25 Psoriatic arthritis
A trial to find the effect of Ginkgo biloba extract EGb 761® and how safe it is in participants with cognitive impairment associated with po … Ended recruitment

2024-517199-39-00 4 2025-03-19 COGNITIVE IMPAIRMENT ASSOCIATED WITH POST-COVID-19 SYNDROME
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation t … Ended recruitment

2023-510458-18-00 6 2025-03-11 Asthma
A Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine Ended recruitment

2024-512946-41-00 5 2025-03-05 Menstrual Migraine
A Phase 2 Study to Investigate Sonrotoclax combined with Zanubrutinib Versus Zanubrutinib alone in Patients With Previously Untreated Chroni … Ended recruitment

2024-513970-23-00 4 2025-02-27 Previously Untreated Chronic Lymphocytic Leukemia
STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended recruitment

2023-508055-40-00 6 2025-02-18 Obesity
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ( ISLEND- … Ended recruitment

2024-514047-28-00 5 2025-01-27 HIV-1 Infection
A Study to Learn About the Investigational Medicine Called PF-06821497 (mevrometostat) in Men with mCRPC Who Were Previously Treated with Ab … Ended recruitment

2024-511650-50-00 5 2025-01-17 METASTATIC CASTRATION RESISTANT PROSTATE CANCER

Showing 385–408 of 838 trials